Larry D. /fa Horner is Director at NEW RIVER PHARMACEUTICALS INC (NRPH). They have made 3 open-market trades across 3 companies since 2006, most recently 2015-03-12.
CIK 0001101233
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $150K since 2006, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTSI | SELL | 2007-11-14 | 2007-11-16 | $3.12 | $83K | -6.9% | +0.0% | +0.0% |
| NRPH | SELL · 10b5-1 | 2007-01-03 | 2007-01-03 | $54.83 | $822K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2006-12-04 | 2006-12-06 | $49.25 | $1.2M | N/A | N/A | N/A |
| NRPH | SELL | 2006-11-09 | 2006-11-13 | $50.77 | $3.6M | N/A | N/A | N/A |
| CLDA | BUY | 2006-06-13 | 2006-06-15 | $16.27 | $150K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2006-05-18 | 2006-05-19 | $29.01 | $1.0M | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2006-03-20 | 2006-03-22 | $30.86 | $1.1M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.